MAPT and Cognitive impairment: This model exhibited classic AD pathologies, including increased levels of amyloid-beta (Aβ) and tau phosphorylation, proliferation of astrocytes and microglia, reduced synaptic proteins, and cognitive impairments (Huang et al., 2013; Chen et al., 2022).